Inflammatory biomarker trajectories after influenza vaccination in adults with stable coronary disease: A hypothesis-generating randomized study
Archives of Cardiovascular Diseases · 2026-11
DOI: 10.1016/j.acvd.2026.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Cardiovascular Diseases, 2026-11. Verfasst von Amal Aïdoud und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Federation of Cardiology.
Abstract (Originalsprache)
Background
Beyond infection prevention, influenza vaccination has been associated with cardiovascular benefit in patients with coronary artery disease, although the underlying mechanisms remain incompletely understood.
Aim
To assess the short-term immunomodulatory effects of influenza vaccination in patients with stable coronary artery disease.
Methods
We conducted a single-centre open-label randomized delayed-start pilot trial to investigate whether influenza vaccination may influence short-term inflammatory activity in stable coronary artery disease. Forty-seven adults aged ≥ 60 years were assigned to immediate influenza vaccination ( n = 24) or delayed influenza vaccination at 1 month (control group; n = 23). The primary endpoint was the between-group difference in 1-month change in high-sensitivity C-reactive protein. Secondary exploratory endpoints included circulating cytokines, immune cell subsets, lipid variables and inflammatory gene expression markers.
Results
At 1 month, between-group differences in high-sensitivity C-reactive protein trajectories reflected attenuation of inflammatory increases in the control group (between-group difference −1.56 mg/L; P = 0.23). A stronger differential pattern was observed in participants with baseline high-sensitivity C-reactive protein ≥ 2 mg/L ( P interaction = 0.07). Directionally consistent relative patterns were observed for inflammatory mediators, notably interleukin-18 (−26.0%), monocyte chemoattractant protein-1 (−27.3%) and interleukin-8 (−28.0%), with interleukin-18 accentuated in the high-inflammation subgroup. These changes were accompanied by a shift toward a more counter-regulatory interleukin-6/interleukin-10 balance and a trend toward lower concentrations of N-terminal prohormone of B-type natriuretic peptide. Immune cell profiles, gene expression and lipid variables remained stable, and influenza-specific immunoglobulin G titres were unrelated to high-sensitivity C-reactive protein changes.
Conclusions
These findings provide preliminary insights into the short-term immunological profile following influenza vaccination in stable coronary artery disease, and may help to inform the design, timing and endpoints of future mechanistic studies.
Förderung
- French Federation of Cardiology
Zitieren
APA
Aïdoud, A., Radenen, L., Fougère, B., Debacq, C., Desvignes, C., Ternant, D., Ivanes, F., Silva, A. V. D., Bonte, S., Roger, S., Poupin, P., & Angoulvant, D. (2026). Inflammatory biomarker trajectories after influenza vaccination in adults with stable coronary disease: A hypothesis-generating randomized study. Archives of Cardiovascular Diseases. https://doi.org/10.1016/j.acvd.2026.07.007
Vancouver
Aïdoud A, Radenen L, Fougère B, Debacq C, Desvignes C, Ternant D, et al. Inflammatory biomarker trajectories after influenza vaccination in adults with stable coronary disease: A hypothesis-generating randomized study. Archives of Cardiovascular Diseases. 2026. doi:10.1016/j.acvd.2026.07.007
BibTeX
@article{Adoud2026,
author = {Aïdoud, Amal and Radenen, Laura and Fougère, Bertrand and Debacq, Camille and Desvignes, Céline and Ternant, David and Ivanes, Fabrice and Silva, Ana-Valéria Vinhais da and Bonte, Stéphanie and Roger, Sébastien and Poupin, Pierre and Angoulvant, Denis},
title = {Inflammatory biomarker trajectories after influenza vaccination in adults with stable coronary disease: A hypothesis-generating randomized study},
journal = {Archives of Cardiovascular Diseases},
year = {2026},
doi = {10.1016/j.acvd.2026.07.007}
}
EUVIMED